From:  Peptide treatment of human plasma disrupts metabolic and age-related pathologies via heat shock protein 70

 Statistics for thioflavin-T measurements.

ComparisonsSamplesMean diff.95.00% CI of diff.Adjusted p-value
Veh vs. 0.1 µM9 vs. 933.081.64 to 64.510.0360
Veh vs. 1 µM9 vs. 633.482.05 to 64.920.0331
Veh vs. 10 µM9 vs. 634.883.44 to 66.310.0247
Veh vs. inhib9 vs. 6–24.51–59.66 to 10.630.2530

Veh: vehicle; inhib: inhibitor; diff.: difference.